Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation
2017 · New England Journal of Medicine · 3,073 citations
https://doi.org/10.1056/nejmoa1706450
S
Suzette Delaloge
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
822
Papers
36.6K
Citations
88
h-index
294
i10-index
Suzette Delaloge is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research. The author has an h-index of 88, co-authored 699 publications.
ORCID: 0000-0003-2106-9165Papers by this author
works70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
2016 · New England Journal of Medicine · 1,957 citations
https://doi.org/10.1056/nejmoa1602253
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
2019 · Annals of Oncology · 736 citations
https://doi.org/10.1093/annonc/mdz012
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
2021 · Annals of Oncology · 702 citations
https://doi.org/10.1016/j.annonc.2021.05.801
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2016 · The Lancet Oncology · 551 citations
https://doi.org/10.1016/s1470-2045(15)00551-3
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
2020 · Nature Reviews Clinical Oncology · 416 citations
https://doi.org/10.1038/s41571-020-0388-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat